Antonio Messina is Chief Executive Officer and Chairman of Merck Serono S.p.A.
Hired in April 1999 as Director of its neurological line, in 2003 he was appointed first Greek Country Manager and then General Manager of Greece and Italy. Before starting his experience in Merck, Messina held various positions in Bayer and Rhone Poulenc Rorer. In the latter company he was first oncology product manager for the UK and, later, marketing manager of the same line for the Italian structure. Since 2014 he has been a member of the Farmindustria Presidential Board and, since 2017, Vice president of Farmindustria.
Messina graduated in biology from La Sapienza University in Rome and completed his training with an MBA Strategic Executive Program at Babson College in Boston, a finance for executive course at INSEAD in Milan and Biopharma Breakthrough 2008 at London Business School. In 2016, the University of Bari awarded him an honorary degree in chemistry and pharmaceutical technology.